Hearts and Minds: Aiming to make a positive impact

Millennials are leading a global investment revolution, driving a change in how the super-rich invest their money. Ethical and sustainable investing is booming and poised to accelerate.

Simon Herrman

Hearts and Minds: Aiming to make a positive impact

November 13, 2018
Millennials are leading a global investment revolution, driving a change in how the super-rich invest their money. Ethical and sustainable investing is booming and poised to accelerate.
Read Transcript

Millennials are leading a global investment revolution, driving a change in how the super-rich invest their money.

According to a survey by Nuveen — one of the world’s largest investment managers — some 92 per cent of millennials agreed with the statement: “I care more about having a positive impact on society than doing well financially.”

Ethical and sustainable investing is booming and poised to accelerate. In fact, it is predicted that it will be one of the most important investment mega trends of the next decade.

The coming $500 million IPO of Hearts and Minds Investments deserves attention, mainly because it serves a greater purpose. Listing at $2.50 a share, Hearts and Minds offers investors exposure to a high-conviction portfolio of global equities from a selected group of fund managers such as Magellan, Regal or Caledonia, while also supporting Australian medical research institutes.

Fund managers and board members have waived their fees so the company can donate 1.5 per cent per annum of the average net asset value to a list of designated charities, regardless of performance. The rich backers of this float only participate as they expect to generate a healthy financial return, but combining these two goals is what modern investing looks like. At the time of listing the NAV is expected to be in line with the $2.50 offer price as all offer costs are paid by the Victor Chang Institute.

The company will allocate 60 per cent of the portfolio to stock picks from “star” fund managers and the other 40 per cent will be invested in recommendations presented at the Sohn Heart and Minds Investment Leaders Conference.

The success and profitability of the Hearts and Minds fund will depend on individual selections and there is a risk of capital loss just as with any other fund. But the concentration risk of the portfolio is somewhat limited due to the influence of a range of fund managers with different investment philosophies.

Overall, the IPO brings a high calibre team of fund managers with a strong track record of value creation while supporting a good cause. The float has been well marketed, and I hope this project delivers on its promise and prompt other fund managers to follow suit.

Simon Herrmann is an investment analyst at wise-owl.com

 

Licensed by Copyright Agency. You must not copy this work without permission.

Millennials are leading a global investment revolution, driving a change in how the super-rich invest their money.

According to a survey by Nuveen — one of the world’s largest investment managers — some 92 per cent of millennials agreed with the statement: “I care more about having a positive impact on society than doing well financially.”

Ethical and sustainable investing is booming and poised to accelerate. In fact, it is predicted that it will be one of the most important investment mega trends of the next decade.

The coming $500 million IPO of Hearts and Minds Investments deserves attention, mainly because it serves a greater purpose. Listing at $2.50 a share, Hearts and Minds offers investors exposure to a high-conviction portfolio of global equities from a selected group of fund managers such as Magellan, Regal or Caledonia, while also supporting Australian medical research institutes.

Fund managers and board members have waived their fees so the company can donate 1.5 per cent per annum of the average net asset value to a list of designated charities, regardless of performance. The rich backers of this float only participate as they expect to generate a healthy financial return, but combining these two goals is what modern investing looks like. At the time of listing the NAV is expected to be in line with the $2.50 offer price as all offer costs are paid by the Victor Chang Institute.

The company will allocate 60 per cent of the portfolio to stock picks from “star” fund managers and the other 40 per cent will be invested in recommendations presented at the Sohn Heart and Minds Investment Leaders Conference.

The success and profitability of the Hearts and Minds fund will depend on individual selections and there is a risk of capital loss just as with any other fund. But the concentration risk of the portfolio is somewhat limited due to the influence of a range of fund managers with different investment philosophies.

Overall, the IPO brings a high calibre team of fund managers with a strong track record of value creation while supporting a good cause. The float has been well marketed, and I hope this project delivers on its promise and prompt other fund managers to follow suit.

Simon Herrmann is an investment analyst at wise-owl.com

 

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Nov 13, 2018. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
September 6, 2024

Exploring HM1 Top Stocks: Key Insights from Reporting Season

We have just come to the end of reporting season and the fund managers of our major portfolio holdings gave us their insights into the latest results of our key holdings.

Read More
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
March 7, 2024

Exploring HM1 Stocks: Key Insights from Reporting Season

We asked our fund managers for an update on how some of our key positions are performing off the back of the reporting season. Overall, it was a good period for the fund with some good moves to the upside.

Read More
February 6, 2024

Stock Story: ResMed

This month we take a deep dive into ResMed - one of the conference stocks within the fund that was astutely picked by Chris Kourtis of Ellerston Capital.

Read More
Ms Lorraine Berends. Director Qantas Super Fund, Pinnacle Investment Management Received an AM in the 2024 Australia Day Honours.Ms Lorraine Berends. Director Qantas Super Fund, Pinnacle Investment Management Received an AM in the 2024 Australia Day Honours.Ms Lorraine Berends. Director Qantas Super Fund, Pinnacle Investment Management Received an AM in the 2024 Australia Day Honours.Ms Lorraine Berends. Director Qantas Super Fund, Pinnacle Investment Management Received an AM in the 2024 Australia Day Honours.
January 25, 2024

Australia Day Honours: Lorraine Berends of Qantas Super

Congratulations to our Board of Director, Lorraine Berends, who was awarded AM in the Australia Day honours.

Read More
January 25, 2024

Fowler toasts Sohn legacy

Grounds, Fowler, and Weiss set up the Australian version, the Sohn Hearts & Minds conference in 2016, with the first meeting at the Sydney Opera House.

Read More
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
December 5, 2023

Guzman y Gomez | Performance Update

Guzman y Gomez (GYG) held its Annual General Meeting on 30 November and provided an update on its FY24 year-to-date results.

Read More
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts